AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cornelis, M. C
Right arrow Articles by Campos, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cornelis, M. C
Right arrow Articles by Campos, H.
Agricola
Right arrow Articles by Cornelis, M. C
Right arrow Articles by Campos, H.
American Journal of Clinical Nutrition, Vol. 86, No. 1, 240-244, July 2007
© 2007 American Society for Nutrition

ORIGINAL RESEARCH COMMUNICATION

Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption1,2,3

Marilyn C Cornelis, Ahmed El-Sohemy and Hannia Campos

1 From the Department of Nutritional Sciences, University of Toronto, Canada (MCC and AE-S); the Department of Nutrition, Harvard School of Public Health, Boston, MA (HC); and the Centro Centroamericano de Poblacion, Universidad de Costa Rica, San Pedro de Montes de Oca, Costa Rica (HC)

Background: Caffeine is the most widely consumed stimulant in the world, and individual differences in response to its stimulating effects may explain some of the variability in caffeine consumption within a population.

Objective: We examined whether genetic variability in caffeine metabolism [cytochrome P450 1A2 (CYP1A2) –163A->C] or the main target of caffeine action in the nervous system [adenosine A2A receptor (ADORA2A) 1083C->T] is associated with habitual caffeine consumption.

Design: Subjects (n = 2735) were participants from a study of gene-diet interactions and risk of myocardial infarction who did not have a history of hypertension. Genotype frequencies were examined among persons who were categorized according to their self-reported daily caffeine intake, as assessed with a validated food-frequency questionnaire.

Results: The ADORA2A, but not the CYP1A2, genotype was associated with different amounts of caffeine intake. Compared with persons consuming <100 mg caffeine/d, the odds ratios for having the ADORA2A TT genotype were 0.74 (95% CI: 0.53, 1.03), 0.63 (95% CI: 0.48, 0.83), and 0.57 (95% CI: 0.42, 0.77) for those consuming 100–200, >200–400, and >400 mg caffeine/d, respectively. The association was more pronounced among current smokers than among nonsmokers (P for interaction = 0.07). Persons with the ADORA2A TT genotype also were significantly more likely to consume less caffeine (ie, <100 mg/d) than were carriers of the C allele [P = 0.011 (nonsmokers), P = 0.008 (smokers)].

Conclusion: Our findings show that the probability of having the ADORA2A 1083TT genotype decreases as habitual caffeine consumption increases. This observation provides a biologic basis for caffeine consumption behavior and suggests that persons with this genotype may be less vulnerable to caffeine dependence.

Key Words: Caffeine • ADORA2A • adenosine A2A receptor gene • CYP1A2 • cytochrome P450 1A2 • genotype • epidemiology • dependence






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition